stockportfolio.pro
Sarepta Therapeutics, Inc. Gross Profit 2009–2025
Sarepta Therapeutics, Inc. (SRPT) annual gross profit by fiscal year, computed from SEC filings. Compound growth +45.7%/yr over 16 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $2.17B | 98.8% | — |
| FY 2024 | — | — | — |
| FY 2023 | — | — | — |
| FY 2022 | — | — | — |
| FY 2021 | — | — | — |
| FY 2020 | — | — | — |
| FY 2019 | — | — | — |
| FY 2018 | — | — | — |
| FY 2017 | — | — | — |
| FY 2016 | $5.29M | 97.6% | — |
| FY 2015 | — | — | — |
| FY 2014 | — | — | — |
| FY 2013 | — | — | — |
| FY 2012 | — | — | — |
| FY 2011 | — | — | — |
| FY 2010 | — | — | — |
| FY 2009 | — | — | — |
Source: Sarepta Therapeutics, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Sarepta Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeSarepta Therapeutics, Inc. — frequently asked questions
What is Sarepta Therapeutics, Inc.'s gross profit?
Sarepta Therapeutics, Inc. (SRPT) reported gross profit of $2.17B for fiscal year 2025, per its SEC filings.
How has Sarepta Therapeutics, Inc.'s gross profit changed over time?
Between fiscal 2009 and 2025, SRPT's gross profit grew at roughly 45.7% per year (compound annual rate), from $5.29M to $2.17B.
Where does this data come from?
Figures are computed from Sarepta Therapeutics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.